This public announcement seeks to notify public health and public safety, law enforcement, clinicians, medical examiners and coroners, laboratory personnel, drug treatment providers, and other related communities about new information about the emergent synthetic stimulant, N,N-dimethylpentylone.
This brief document provides information about the emergent synthetic stimulant, N,N-dimethylpentylone, which was first identified in the U.S. toxicology samples in the third quarter of 2021. The document provides a general background about synthetic stimulants, noting that they are chemically manufactured drugs with sub-classifications based on their structural relation to amphetamine or cathinone. The announcement also provides demographic information about users, including age and sex, and geographical distribution in the U.S. The fact sheet also depicts the structure of the N,N-dimethylpentylone molecule, and provides recommendations for public health, clinicians, medical examiners and coroners, and laboratories.
- Fast On-site Screening of Seized Drugs by Electrochemical and Spectroscopic Tools: Identification of Fentanyl and Novel Psychoactive Substances
- Differentiation of Structurally Similar Phenethylamines via Gas Chromatography-Vacuum Ultraviolet Spectroscopy (GC-VUV)
- GC-MS and GC-IRD Studies on Dimethoxyamphetamines (DMA): Regioisomers Related to 2,5-DMA